Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
NovoCure Limited Ordinary Shares (NVCR) has a market cap of $1.29B with year-over-year revenue growth of +18.8%. Net margin stands at -27.9%. The stock trades at a P/E ratio of -7.6.
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, NVCR posted revenue growth of +18.8% and trades at a P/E of -7.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.